The most recent Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend a regular assessment of haemoglobin (Hb) levels in patients with CKD, increasing the frequency as kidney function declines [5]. This evidence concerns the gene GSTM1 and chronic kidney disease.